Lawrence Klein

Director at Dyne Therapeutics


Dr. Klein is currently chief business officer at CRISPR Therapeutics, where he previously served as vice president of strategy and corporate development. Before joining CRISPR, he was an associate partner at McKinsey & Company, where he was a leader in the biotech practice and served a number of biotech companies on a wide range of topics, from strategy to operations. He received his B.S. in biochemistry and physics from the University of Wisconsin-Madison and his Ph.D. in biophysics from Stanford University.


  • Director

    Current role

The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.